Samsung Biologics signs largest manufacturing deal with Asia-based pharmaceutical company ...Middle East

INCHEON, South Korea, Oct. 21, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced today a contract manufacturing deal with an Asia-based pharmaceutical company. The disclosed deal, worth USD 1.24 billion,...

Hence then, the article about samsung biologics signs largest manufacturing deal with asia based pharmaceutical company was published today ( Tuesday 22/10/2024 - 02:57 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Samsung Biologics signs largest manufacturing deal with Asia-based pharmaceutical company )

Also on site :

• Sewage treatment and desalination: Saudi Arabia’s core infrastructure opportunity – World Construction Network
• 1975 Soft Rock Classic, Originally Disliked by '70s Songwriter, Became a No. 1 Hit
• Today's NYT Mini Crossword Answers for May 8 – CNET